Intrathecal Pumps Market

Intrathecal Pumps Market (Product Type: Programmable and Constant Rate; Application: Chronic Pain and Spasticity Management) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Intrathecal Pumps Market Outlook 2031

  • The global industry was valued at US$ 272.1 Mn in 2021
  • It is projected to grow at a CAGR of 4.5% from 2022 to 2031 and reach more than US$ 405.6 Mn by 2031

Analysts’ Viewpoint

Intrathecal pain pump implants have the ability to reduce debilitating pain and administer a drug in low doses. These implants offer lesser side-effects and more rapid therapeutic action as compared to other forms of medication. Increase in number of people in the U.S. suffering from chronic pain is driving intrathecal pumps demand. Prevalence of chronic pain is also rising in other parts of the world. Surge in demand for intrathecal pump implants for the treatment of chronic pain is likely to propel market progress in the next few years.

Researchers have developed advanced intrathecal drug pump that can deliver multiple intrathecal pump medications via a single infusion pump. However, usage of combination therapy in a single reservoir could result in drug stability issues and a complex dosing challenge with respect to varying concentration and administration rates for each drug. Furthermore, recent recall of intrathecal pumps owing to battery failure and broken components is hampering business growth. More product modifications are required to assure precise and accurate drug administration with minimal error.

Intrathecal Pumps Market

Intrathecal Pumps Market Introduction

Intrathecal pumps are implantable infusion devices surgically placed under the patient’s skin in the abdomen. These can deliver medication through a small flexible tube, called a catheter, to the spine. These intrathecal drug pain pump implants are capable of delivering precise doses of medication from one or any combination of reservoirs without complex pumping, and are generally opted when a patient seeks long-term medication and other alternatives are expensive or less effective.

A drug can be infused over an extended period and can be delivered at constant or variable rates by regulating the intrathecal pumps drug delivery as per physician specifications. The drug reservoir is refilled with the help of an external needle injection via a self-sealing septum in the implantable infusion pump. These pumps are intended for use in spasticity management and chronic pain for delivering potent medicines in the intrathecal space, which allows the administration of drugs in very low doses. This reduces the side effects associated with the drugs.

Intrathecal drug delivery is based on the principle that effective analgesia can be achieved with the help of certain drugs, wherein adequate concentrations cannot be achieved by systemic administration or require high systemic doses. The smaller doses needed for intrathecal drug administration also reduce the side-effects as compared to systemic administration.

Request a sample to get extensive insights into the Intrathecal Pumps Market

COVID-19 Impact on Intrathecal Pumps Market Size

The COVID-19 pandemic had a negative effect on the industry. Several countries had to postpone non-essential surgeries and patient visits during the breakout year of COVID-19. Healthcare assets such as ventilators, personal protective equipment, and medical staff were rerouted for the management of the pandemic, which prompted the suspension of spinal surgery during the pandemic. This led to a substantial decline in overall non-emergency procedures and treatments.

The pandemic affected various procedures such as intrathecal device placement and procedure feasibility testing. Companies in the intrathecal pumps business reported a decline in revenue and demand due to the pandemic. However, demand is showing signs of recovery, as restrictions on movement ease across the globe.

Increase in Patient Base Affected with Chronic Pain and Cancer

Increase in number of people suffering from chronic pain and cancer is a major factor fueling the global market. Intrathecal pumps are widely used to administer drugs using the intrathecal route during the treatment of these diseases. According to International Agency for Research on Cancer (IARC) estimates, around 17.0 million new cancer cases and 9.5 million cancer deaths were reported globally in 2018. The global burden is expected to increase to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040 due to surge in the geriatric population.

Changing lifestyles, rapid urbanization, and demographic changes are major factors contributing to the increase in people with disease-causing pain. Thus, rise in prevalence of chronic pain and pain related to cancer is expected to drive the demand for intrathecal pumps for managing cancer pain.

Request a custom report on Intrathecal Pumps Market

Technologically Advanced Products with Improved Features

Technological developments are bolstering the global intrathecal pumps business. The trend is expected to continue during the forecast period. Manufacturers are focusing on the development of innovative products in order to gain a competitive edge over the competitors. Advent of a smart intrathecal pumps management system helps clinicians with programming and calculating dose delivery rates, thereby helping in providing better patient care. These innovations have driven the demand for intrathecal infusion pumps. Technological developments leading to enhanced product performance are expected to drive the market from 2022 to 2031.

Rise in Product Launches and Regulatory Approvals Propelling Programmable Segment

In terms of product type, the programmable segment accounted for major intrathecal pumps market share in 2021. In February 2020, Flowonix Medical, Inc. announced the U.S. Food and Drug Administration (FDA) approval to commercialize the Prometra ii programmable pump system for use with intrathecal baclofen. Flowonix introduced the Prometra II 40mL pump in the U.S. in November 2019.

Likewise, in April 2017, Medtronic announced the U.S. Food and Drug Administration (FDA) approval to market the SynchroMed II GW3/FT/DLC pump system, a programmable intrathecal pump. Thus, increase in launch of new products is likely to augment the programmable segment during the forecast period.

Controlled Administration of Drugs Bolstering Chronic Pain Segment

Based on application, the chronic pain segment dominated the global intrathecal pumps industry in 2021. The segment is projected to grow at a moderate pace during the forecast period. Intrathecal pumps have shown significant improvement in patients with chronic pain by enabling the controlled administration of drugs.

Furthermore, the prevalence of chronic pain is high across the world. In a study published by a national health publication, around 20% of the U.S. adults experienced chronic pain in 2020, with an estimated US$ 560 Bn spent annually on direct medical costs. Therefore, increase in new cases of chronic pain is propelling the chronic pain segment.

Availability of Adequate Infrastructure to Perform Surgery Fueling Hospitals Segment

In terms of end-user, the hospitals segment accounted for major share of the global market in 2021. Around 80% to 90% of intrathecal procedures are performed at hospitals owing to availability of adequate infrastructure and specialists. However, the ambulatory surgical centers segment is projected to grow at a rapid pace during the forecast period due to rise in reimbursement and increase in approvals for intrathecal procedures in these settings.

Regional Outlook of Global Intrathecal Pumps Market

North America accounted for largest share of the global market for intrathecal pumps in 2021. The region is anticipated to dominate the industry during the forecast period. Surge in demand for intrathecal procedures, high prevalence of cancer & chronic pain, and technological advancements are driving market expansion in the region. The U.S. is a growth engine of the market in North America due to the implementation of favorable reimbursement policies for intrathecal procedures.

Europe was the second largest market in 2021. Favorable regulatory & reimbursement scenarios and approval of intrathecal devices are expected to propel intrathecal pumps market growth in the region. The market in Asia Pacific is projected to grow at a rapid pace during the forecast period. This is ascribed to growing economy and strengthening insurance policies. Economic growth in developing countries in the region is expected to increase the disposable income of the patient population, which in turn is likely to propel healthcare expenditure.

Economic growth has also increased healthcare infrastructure investment in several countries in Asia, which is likely to drive the adoption of hospital equipment. Governments in these nations in collaboration with private insurance companies are focusing on the improvement of healthcare coverage in order to support access to better healthcare facilities.

Analysis of Key Players

This report includes vital information about the key players operating in the global intrathecal pumps market. Companies focus on diverse strategies such as product launches, divestiture, merger & acquisition (M&A), and partnerships to strengthen their position in the market. Medtronic, Inc., Flowonix, Inc. and Tricumed Medizintechnik GmbH are the prominent players operating in this market.

Key Developments

  • In February 2020, Flowonix Medical, Inc. announced the U.S. Food and Drug Administration (FDA) marketing approval for Prometra II Programmable Pump System for use with intrathecal baclofen. The company introduced the Prometra II 40mL pump in the U.S. in November 2019.
  • In October 2019, the FDA classified the recall of Medtronic’s SynchroMed II implantable drug pumps as Class I, the most serious type of recall. The company announced the voluntary recall in October, indicating that it had received complaints about the pumps’ motors stalling permanently.
  • In March 2019, the U.S. Food and Drug Administration (FDA) ordered Flowonix Medical, Inc. to recall Prometra II Programmable Pump from the market. Increase in Error 115 occurrences was noted due to a software associated with the pumps.

Players in the report have been profiled based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.

Market Snapshot

Attribute

Detail

Size in 2021

US$ 272.1 Mn

Forecast (Value) in 2031

More than US$ 405.6 Mn

Compound Annual Growth Rate (CAGR)

4.5%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis/ranking by company (2021)
  • Company profiles section includes overview, product portfolio, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Product Type
    • Programmable
    • Constant Rate
  • Application
    • Chronic Pain
    • Spasticity Management
  • End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Medtronic, Inc.
  • Flowonix, Inc.
  • Tricumed Medizintechnik GmbH

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global intrathecal pumps market in 2021?

The industry was valued at US$ 272.1 Mn in 2021

How big will it be by 2031?

It is projected to reach more than US$ 405.6 Mn by 2031

What will be the CAGR during the forecast period?

The industry is anticipated to grow at a CAGR of 4.5% from 2022 to 2031

Which are the prominent trends that affect market growth?

Increase in adoption of programmable pumps and rise in in prevalence of chronic pain

What was the share of the leading segment?

The programmable pumps segment held largest share of 81.4% in 2021

Which region will account for major share during the forecast period?

North America is expected to account for major share of the business during the forecast period

Who are the prominent players in the global intrathecal pumps market?

Medtronic, Inc., Flowonix, Inc., and Tricumed Medizintechnik GmbH

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Intrathecal Pumps Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Intrathecal Pumps Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Market Outlook

        5.1. Disease incidence and prevalence

        5.2. Technological Advancements

        5.3. Regulatory Scenario across the globe/key countries

        5.4. COVID-19 Impact Analysis

    6. Global Intrathecal Pumps Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product Type, 2017–2031

            6.3.1. Programmable

            6.3.2. Constant Rate

        6.4. Market Attractiveness Analysis, by Product Type

    7. Global Intrathecal Pumps Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Chronic Pain

            7.3.2. Spasticity Management

        7.4. Market Attractiveness Analysis, by Application

    8. Global Intrathecal Pumps Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Ambulatory Surgical Centers

            8.3.3. Others

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Intrathecal Pumps Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Intrathecal Pumps Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product Type, 2017–2031

            10.2.1. Programmable

            10.2.2. Constant Rate

        10.3. Market Value Forecast, by Application, 2017–2031

            10.3.1. Chronic Pain

            10.3.2. Spasticity Management

        10.4. Market Value Forecast, by End-user, 2017–2031

            10.4.1. Hospitals

            10.4.2. Ambulatory Surgical Centers

            10.4.3. Others

        10.5. Market Value Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Product Type

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Intrathecal Pumps Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product Type, 2017–2031

            11.2.1. Programmable

            11.2.2. Constant Rate

        11.3. Market Value Forecast, by Application, 2017–2031

            11.3.1. Chronic Pain

            11.3.2. Spasticity Management

        11.4. Market Value Forecast, by End-user, 2017–2031

            11.4.1. Hospitals

            11.4.2. Ambulatory Surgical Centers

            11.4.3. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. U.K.

            11.5.2. Germany

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Product Type

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Intrathecal Pumps Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product Type, 2017–2031

            12.2.1. Programmable

            12.2.2. Constant Rate

            12.2.3. Others

        12.3. Market Value Forecast, by Application, 2017–2031

            12.3.1. Chronic Pain

            12.3.2. Spasticity Management

        12.4. Market Value Forecast, by End-user, 2017–2031

            12.4.1. Hospitals

            12.4.2. Ambulatory Surgical Centers

            12.4.3. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Product Type

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Intrathecal Pumps Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product Type, 2017–2031

            13.2.1. Programmable

            13.2.2. Constant Rate

        13.3. Market Value Forecast, by Application, 2017–2031

            13.3.1. Chronic Pain

            13.3.2. Spasticity Management

        13.4. Market Value Forecast, by End-user, 2017–2031

            13.4.1. Hospitals

            13.4.2. Ambulatory Surgical Centers

            13.4.3. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Product Type

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Intrathecal Pumps Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product Type, 2017–2031

            14.2.1. Programmable

            14.2.2. Constant Rate

        14.3. Market Value Forecast, by Application, 2017–2031

            14.3.1. Chronic Pain

            14.3.2. Spasticity Management

        14.4. Market Value Forecast, by End-user, 2017–2031

            14.4.1. Hospitals

            14.4.2. Ambulatory Surgical Centers

            14.4.3. Others

        14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Product Type

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player – Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company, 2021

        15.3. Company Profiles

            15.3.1. Medtronic, Inc.

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Product Portfolio

                15.3.1.3. Financial Overview

                15.3.1.4. SWOT Analysis

                15.3.1.5. Strategic Overview

            15.3.2. Flowonix, Inc.

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Product Portfolio

                15.3.2.3. Financial Overview

                15.3.2.4. SWOT Analysis

                15.3.2.5. Strategic Overview

            15.3.3. Tricumed Medizintechnik GmbH

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Product Portfolio

                15.3.3.3. Financial Overview

                15.3.3.4. SWOT Analysis

                15.3.3.5. Strategic Overview

    List of Tables

    Table 01: Global Intrathecal Pumps Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 02: Global Intrathecal Pumps Market Value (US$ Mn) Forecast, by Programmable, 2017–2031

    Table 03: Global Intrathecal Pumps Market Value (US$ Mn) Forecast, by Constant Rate, 2017–2031

    Table 04: Global Intrathecal Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 05: Global Intrathecal Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 06: Global Intrathecal Pumps Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 07: North America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 08: North America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Programmable, 2017–2031

    Table 09: North America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Constant Rate, 2017–2031

    Table 10: North America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 11: North America Intrathecal Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 12: North America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 13: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 14: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast, by Programmable, 2017–2031

    Table 15: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast, by Constant Rate, 2017–2031

    Table 16: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 17: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 18: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 19: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 20: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast, by Programmable, 2017–2031

    Table 21: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast, by Constant Rate, 2017–2031

    Table 22: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 23: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 24: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 25: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 26: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Programmable, 2017–2031

    Table 27: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Constant Rate, 2017–2031

    Table 28: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 29: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 30: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 31: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 32: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast, by Programmable, 2017–2031

    Table 33: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast, by Constant Rate, 2017–2031

    Table 34: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 35: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 36: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    List of Figures

    Figure 01: Global Intrathecal Pumps Market

    Figure 02: Global Intrathecal Pumps Market Size (US$ Mn) Forecast, 2017–2031

    Figure 03: Global Intrathecal Pumps Market Value Share, by Product Type (2021)

    Figure 04: Global Intrathecal Pumps Market Value Share, by Application (2021)

    Figure 05: Global Intrathecal Pumps Market Value Share, by End-user (2021)

    Figure 06: Global Intrathecal Pumps Market Value Share, by Region (2021)

    Figure 07: Global Intrathecal Pumps Market Value Share, by Product Type, 2021 and 2031

    Figure 08: Global Intrathecal Pumps Market Attractiveness Analysis, by Product Type, 2021–2031

    Figure 09: Global Intrathecal Pumps Market Value Share, by Application, 2021 and 2031

    Figure 10: Global Intrathecal Pumps Market Attractiveness Analysis, by Application, 2021–2031

    Figure 11: Global Intrathecal Pumps Market Value Share, by End-user, 2021 and 2031

    Figure 12: Global Intrathecal Pumps Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 13: Global Intrathecal Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031

    Figure 14: Global Intrathecal Pumps Market Value Share, by Region, 2021–2031

    Figure 15: Global Intrathecal Pumps Market Attractiveness Analysis, by Region, 2021–2031

    Figure 16: North America Intrathecal Pumps Market Value Share, by Product Type, 2021 and 2031

    Figure 17: North America Intrathecal Pumps Market Attractiveness Analysis, by Product Type, 2021–2031

    Figure 18: North America Intrathecal Pumps Market Value Share, by Application, 2021 and 2031

    Figure 19: North America Intrathecal Pumps Market Attractiveness Analysis, by Application, 2021–2031

    Figure 20: North America Intrathecal Pumps Market Value Share, by End-user, 2021 and 2031

    Figure 21: North America Intrathecal Pumps Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 22: North America Intrathecal Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031

    Figure 23: North America Intrathecal Pumps Market Value Share, by Country, 2021–2031

    Figure 24: North America Intrathecal Pumps Market Attractiveness Analysis, by Country, 2021–2031

    Figure 25: Europe Intrathecal Pumps Market Value Share, by Product Type, 2021 and 2031

    Figure 26: Europe Intrathecal Pumps Market Attractiveness Analysis, by Product Type, 2021–2031

    Figure 27: Europe Intrathecal Pumps Market Value Share, by Application, 2021 and 2031

    Figure 28: Europe Intrathecal Pumps Market Attractiveness Analysis, by Application, 2021–2031

    Figure 29: Europe Intrathecal Pumps Market Value Share, by End-user, 2021 and 2031

    Figure 30: Europe Intrathecal Pumps Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 31: Europe Intrathecal Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031

    Figure 32: Europe Intrathecal Pumps Market Value Share, by Country/Sub-region, 2021–2031

    Figure 33: Europe Intrathecal Pumps Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 34: Asia Pacific Intrathecal Pumps Market Value Share, by Product Type, 2021 and 2031

    Figure 35: Asia Pacific Intrathecal Pumps Market Attractiveness Analysis, by Product Type, 2021–2031

    Figure 36: Asia Pacific Intrathecal Pumps Market Value Share, by Application, 2021 and 2031

    Figure 37: Asia Pacific Intrathecal Pumps Market Attractiveness Analysis, by Application, 2021–2031

    Figure 38: Asia Pacific Intrathecal Pumps Market Value Share, by End-user, 2021 and 2031

    Figure 39: Asia Pacific Intrathecal Pumps Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 40: Asia Pacific Intrathecal Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031

    Figure 41: Asia Pacific Intrathecal Pumps Market Value Share, by Country/Sub-region, 2021–2031

    Figure 42: Asia Pacific Intrathecal Pumps Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 43: Latin America Intrathecal Pumps Market Value Share, by Product Type, 2021 and 2031

    Figure 44: Latin America Intrathecal Pumps Market Attractiveness Analysis, by Product Type, 2021–2031

    Figure 45: Latin America Intrathecal Pumps Market Value Share, by Application, 2021 and 2031

    Figure 46: Latin America Intrathecal Pumps Market Attractiveness Analysis, by Application, 2021–2031

    Figure 47: Latin America Intrathecal Pumps Market Value Share, by End-user, 2021 and 2031

    Figure 48: Latin America Intrathecal Pumps Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 49: Latin America Intrathecal Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031

    Figure 50: Latin America Intrathecal Pumps Market Value Share, by Country/Sub-region, 2021–2031

    Figure 51: Latin America Intrathecal Pumps Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 52: Middle East & Africa Intrathecal Pumps Market Value Share, by Product Type, 2021 and 2031

    Figure 53: Middle East & Africa Intrathecal Pumps Market Attractiveness Analysis, by Product Type, 2021–2031

    Figure 54: Middle East & Africa Intrathecal Pumps Market Value Share, by Application, 2021 and 2031

    Figure 55: Middle East & Africa Intrathecal Pumps Market Attractiveness Analysis, by Application, 2021–2031

    Figure 56: Middle East & Africa Intrathecal Pumps Market Value Share, by End-user, 2021 and 2031

    Figure 57: Middle East & Africa Intrathecal Pumps Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 58: Middle East & Africa Intrathecal Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031

    Figure 59: Middle East & Africa Intrathecal Pumps Market Value Share, by Country/Sub-region, 2021–2031

    Figure 60: Middle East & Africa Intrathecal Pumps Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 61: Global Intrathecal Pumps Market Share Analysis, by Company, 2021 (Estimated)

    Figure 62: Global Intrathecal Pumps Market Performance, by Company, 2021

    Figure 63: Competition Matrix Novartis AG and Allergan plc (AbbVie Inc.)

    Figure 64: Competition Matrix Bausch Health Companies Inc. and Alma Lasers (Fosun Pharmaceutical Co., Ltd.)

Copyright © Transparency Market Research, Inc. All Rights reserved